- Home
- SVM vs APLT Comparison
SVM vs APLT Comparison
Compare SVM & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- APLT
- Stock Information
- Founded
- SVM N/A
- APLT 2016
- Country
- SVM Canada
- APLT United States
- Employees
- SVM N/A
- APLT N/A
- Industry
- SVM Precious Metals
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- APLT Health Care
- Exchange
- SVM Nasdaq
- APLT Nasdaq
- Market Cap
- SVM 906.7M
- APLT 44.0M
- IPO Year
- SVM N/A
- APLT 2019
- Fundamental
- Price
- SVM $5.08
- APLT $0.42
- Analyst Decision
- SVM Strong Buy
- APLT Buy
- Analyst Count
- SVM 1
- APLT 7
- Target Price
- SVM $6.75
- APLT $6.10
- AVG Volume (30 Days)
- SVM 6.7M
- APLT 2.7M
- Earning Date
- SVM 08-12-2025
- APLT 08-06-2025
- Dividend Yield
- SVM 0.49%
- APLT N/A
- EPS Growth
- SVM 40.00
- APLT N/A
- EPS
- SVM 0.28
- APLT N/A
- Revenue
- SVM $298,895,000.00
- APLT $265,000.00
- Revenue This Year
- SVM $1.10
- APLT $1,768.13
- Revenue Next Year
- SVM $26.47
- APLT $292.85
- P/E Ratio
- SVM $18.13
- APLT N/A
- Revenue Growth
- SVM 38.90
- APLT N/A
- 52 Week Low
- SVM $2.87
- APLT $0.30
- 52 Week High
- SVM $5.32
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- SVM 69.49
- APLT 60.22
- Support Level
- SVM $4.45
- APLT $0.32
- Resistance Level
- SVM $5.22
- APLT $0.36
- Average True Range (ATR)
- SVM 0.21
- APLT 0.04
- MACD
- SVM 0.06
- APLT 0.01
- Stochastic Oscillator
- SVM 88.70
- APLT 88.67
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.